tiprankstipranks
Trending News
More News >
Lepu Biopharma Co. Ltd. Class H (HK:2157)
:2157
Hong Kong Market
Advertisement

Lepu Biopharma Co. Ltd. Class H (2157) Similar Stocks

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Lepu Biopharma Co. Ltd. Class H
HK$5.11
HK$9.22B
171.92%
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$21.75
HK$8.47B
235.64
159.04%
0 Buy
0 Hold
0 Sell
Hold
CARsgen Therapeutics Holdings Ltd.
HK$24.15
HK$12.90B
448.57%
0 Buy
0 Hold
1 Sell
Moderate Sell
Keymed Biosciences, Inc.
HK$57.25
HK$14.04B
75.30%
0 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$9.85
HK$8.86B
975.93%
0 Buy
1 Hold
0 Sell
Hold
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
HK$10.82
HK$7.62B
-15.38%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.94
5.02
171.92%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
21.50
14.08
189.76%
HK:2171
CARsgen Therapeutics Holdings Ltd.
24.85
20.32
448.57%
HK:2162
Keymed Biosciences, Inc.
57.50
25.45
79.41%
HK:1672
Ascletis Pharma, Inc.
11.62
10.54
975.93%
HK:1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
11.00
-2.00
-15.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis